← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS › ANTIPROPULSIVES › Antipropulsives
loperamide oxide
A07DA05
Forms & Strengths
- Capsules: 2mg
- Tablets: 2mg
- Liquid: 1mg/5mL
Adult Dosing
- Initial dose: 4mg orally after first loose stool
- Maintenance dose: 2mg after each loose stool, up to 16mg/day
- Maximum dose: 16mg/day
Pediatric Dosing
- Children 6-12 years: 1mg/5mL, 1-2 teaspoons (5-10mg) orally after first loose stool
- Children 2-5 years (with doctor supervision): 1mg/5mL, 1 teaspoon (5mg) orally after first loose stool
- Children under 2 years: Not recommended
Indications
- Acute and chronic diarrhea
- Diarrhea associated with inflammatory bowel disease
- Traveler's diarrhea
Mechanism of Action
- Acts on mu-opioid receptors in gut
- Slows intestinal motility
- Allows more time for water and electrolyte absorption
- No significant effect on opiate receptors in the CNS
Contraindications
- Hypersensitivity to loperamide
- Bowel obstruction
- Acute conditions: pseudomembranous colitis, abdominal distension
Adverse Reactions
- Common: constipation, drowsiness, dizziness, nausea
- Less common: allergic reactions, abdominal cramps, bloating
- Rare: toxic megacolon, paralytic ileus, pancreatitis
Drug Interactions
- Increased risk of CNS depression with sedatives, tranquilizers, narcotics
- Reduced effectiveness with antacids, other opioids
- Potential increased risk of torsades de pointes with QTc-prolonging agents
Curated Content: Needs Vetting Before Put to Clinical Use